Point-of-care tests provide an opportunity for providing testing to people who may not otherwise seek testing from medical settings and can enhance linkage to care. This online learning program consists of 6 individual modules (approx. 15 mins each) that outlines the key processes involved in point of care testing for hepatitis C, hepatitis B, and HIV infections using tests accessible in Australia*. This course will cover infection control, methods for sample collection, interpretation of results, and quality control for point-of-care tests for Hepatitis C (INSTI® HCV Antibody Test and BIOLINE™ HCV Antibody Test), Hepatitis B (DETERMINE™ Surface Antigen 2 test), and HIV (Determine™ HIV Early Detect test).
Target audience: This program is designed for healthcare workers who will perform, or supervise the performance of, Hepatitis C, Hepatitis B, or HIV testing using these devices.
This activity was developed, supported and funded by the National Australian Hepatitis C Point-of-Care Testing Program through a collaboration between the Kirby Institute at UNSW Sydney, the International Centre for Point-of-Care Testing at Flinders University, St. Vincent’s Centre for Applied Medical Research and ASHM Health.
*The BIOLINE™ HCV Antibody Test and Hepatitis B DETERMINE™ Surface Antigen 2 test) are not yet approved by the Therapeutics Goods Administration and can only be used as part of research studies.